• Mount Sinai initiates system-wide scaled-up implementation of KidneyIntelX™ early-stage risk assessment testing and care management program across primary care and specialty clinician networks under a real-world evidence development program for patients with diabetic kidney disease (DKD).


  • Payer budget impact analysis projects significant savings from KidneyIntelX™ testing at primary care level, as published in peer-reviewed publication, Journal of Medical Economics.